Biscotti CV - Search Results

1

Expression profile of COL2A1 and the pseudogene SLC6A10P predicts tumor recurrence in high-grade serous ovarian cancer.

Ganapathi MK, Jones WD, Sehouli J, Michener CM, Braicu IE, Norris EJ, Biscotti CV, Vaziri SA, Ganapathi RN. Ganapathi MK, et al. Among authors: biscotti cv. Int J Cancer. 2016 Feb 1;138(3):679-88. doi: 10.1002/ijc.29815. Epub 2015 Sep 10. Int J Cancer. 2016. PMID: 26311224

2

HOXA4/HOXB3 gene expression signature as a biomarker of recurrence in patients with high-grade serous ovarian cancer following primary cytoreductive surgery and first-line adjuvant chemotherapy.

Miller KR, Patel JN, Zhang Q, Norris EJ, Symanowski J, Michener C, Sehouli J, Braicu I, Destephanis DD, Sutker AP, Jones W, Livasy CA, Biscotti C, Ganapathi RN, Tait DL, Ganapathi MK. Miller KR, et al. Gynecol Oncol. 2018 Apr;149(1):155-162. doi: 10.1016/j.ygyno.2018.01.022. Gynecol Oncol. 2018. PMID: 29402501

3

RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers.

Jones WD, Michener CM, Biscotti C, Braicu I, Sehouli J, Ganapathi MK, Ganapathi RN. Jones WD, et al. Cancers (Basel). 2020 Mar 7;12(3):620. doi: 10.3390/cancers12030620. Cancers (Basel). 2020. PMID: 32156016 Free PMC article.

4

CCL2 expression in primary ovarian carcinoma is correlated with chemotherapy response and survival outcomes.

Fader AN, Rasool N, Vaziri SA, Kozuki T, Faber PW, Elson P, Biscotti CV, Michener CM, Rose PG, Rojas-Espaillat L, Belinson JL, Ganapathi MK, Ganapathi R. Fader AN, et al. Among authors: biscotti cv. Anticancer Res. 2010 Dec;30(12):4791-8. Anticancer Res. 2010. PMID: 21187454

5

Isolated cervical metastasis of breast cancer: a case report and review of the literature.

Green AE, Biscotti C, Michener C, Belinson J. Green AE, et al. Gynecol Oncol. 2004 Oct;95(1):267-9. doi: 10.1016/j.ygyno.2004.07.006. Gynecol Oncol. 2004. PMID: 15385145 Review.

6

Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center.

Moline J, Mahdi H, Yang B, Biscotti C, Roma AA, Heald B, Rose PG, Michener C, Eng C. Moline J, et al. Gynecol Oncol. 2013 Jul;130(1):121-6. doi: 10.1016/j.ygyno.2013.04.022. Epub 2013 Apr 20. Gynecol Oncol. 2013. PMID: 23612316

7

p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer.

Eltabbakh GH, Belinson JL, Kennedy AW, Biscotti CV, Casey G, Tubbs RR, Blumenson LE. Eltabbakh GH, et al. Among authors: biscotti cv. Cancer. 1997 Sep 1;80(5):892-8. Cancer. 1997. PMID: 9307189

8

p53 and HER-2/neu overexpression in ovarian borderline tumors.

Eltabbakh GH, Belinson JL, Kennedy AW, Biscotti CV, Casey G, Tubbs RR. Eltabbakh GH, et al. Among authors: biscotti cv. Gynecol Oncol. 1997 May;65(2):218-24. doi: 10.1006/gyno.1997.4661. Gynecol Oncol. 1997. PMID: 9159328

9

Ovarian clear cell adenocarcinoma.

Kennedy AW, Biscotti CV, Hart WR, Webster KD. Kennedy AW, et al. Among authors: biscotti cv. Gynecol Oncol. 1989 Mar;32(3):342-9. doi: 10.1016/0090-8258(89)90637-9. Gynecol Oncol. 1989. PMID: 2920955

10

Elevated blood β-2 microglobulin is associated with tumor monosomy-3 in patients with primary uveal melanoma.

Triozzi PL, Elson P, Aldrich W, Achberger S, Tubbs R, Biscotti CV, Singh AD. Triozzi PL, et al. Among authors: biscotti cv. Melanoma Res. 2013 Feb;23(1):1-7. doi: 10.1097/CMR.0b013e32835b7154. Melanoma Res. 2013. PMID: 23196330

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters